is developing products for :
•  Rapid, or "high-throughput," assays for drug discovery
    and quality control for pharmaceutical companies;
•  In-Vitro Diagnostics for the medical and research markets.
•  Advanced bioagent detection technologies;




is to deliver systems for the detection of viruses, toxins, bacteria, proteins, hormones, nucleic acids and other biological compounds. Our goal is to use our fluorescence superquenching technology to create products characterized by low cost, speed and simplicity.

"QTL" stands for "Quencher-Tether-Ligand," a new technology that was invented by the founders of QTL Biosystems at Los Alamos National Laboratory. Our products are based on a proprietary QTL molecular component that enables a single step, instantaneous, homogeneous assay. The QTL concept enables a remarkably versatile new line of biosensing and biomedical assay products.
» view technology